scholarly journals Dihydropyrimidine Dehydrogenase Is a Prognostic Marker for Mesenchymal Stem Cell-Mediated Cytosine Deaminase Gene and 5-Fluorocytosine Prodrug Therapy for the Treatment of Recurrent Gliomas

Theranostics ◽  
2016 ◽  
Vol 6 (10) ◽  
pp. 1477-1490 ◽  
Author(s):  
Taemoon Chung ◽  
Juri Na ◽  
Young-il Kim ◽  
Da-Young Chang ◽  
Young Il Kim ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document